tirzepatide cv outcomes trial cardiovascular results august 2025 compared with semaglutide and 10-year disease risk reduction in obesity: post-hoc analysis of the SURMOUNT-5 Tirzepatide and the 10‐year predicted – A comparison of the effects

Diana Thiara, an internist at UCSF Health and director of the UCSF Medical Weight Management Program, joined KCBS Radios Alice Wertz on As Prescribed last year to discuss the medications

Weight Watchers stopped offering compounded semaglutide on May 21, 2025, after the FDA issued a warning letter to all compounding pharmacies stating that compounded semaglutide should not be dispensed and distributed unless medically necessary

This eating pattern is similar to how bariatric patients eat after surgery, and for similar reasons

Is GLP-1 safe for everyone

confirmed that daily administration of l-carnitine (400 mg/kg) in drinking water offered complete protection against SUN-induced cardiotoxicity via down-regulating the myocardial expression of inflammatory and fibrotic markers, oxidative stress markers and NF-kB [13]